Related references
Note: Only part of the references are listed.Multiple roles of lymphatic vessels in tumor progression
Qiaoli Ma et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
Nathalie Harder et al.
SCIENTIFIC REPORTS (2018)
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread
Qiaoli Ma et al.
SCIENCE ADVANCES (2018)
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805
Lucia B. Jilaveanu et al.
CLINICAL CANCER RESEARCH (2018)
Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
Lothar C. Dieterich et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Steven A. Mann et al.
CURRENT DRUG METABOLISM (2017)
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Tristan A. Barnes et al.
BRITISH JOURNAL OF CANCER (2017)
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
Nicolas A. Giraldo et al.
CLINICAL CANCER RESEARCH (2017)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
John Kucharczyk et al.
CURRENT DRUG TARGETS (2016)
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F. McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment
Koichi Sakakura et al.
LABORATORY INVESTIGATION (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting
Peter D. Caie et al.
ONCOTARGET (2016)
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centre
Wee Loon Ong et al.
BJU INTERNATIONAL (2015)
Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
Andreas Heindl et al.
LABORATORY INVESTIGATION (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
Marina K. Baine et al.
ONCOTARGET (2015)
Penile vibratory stimulation: a novel approach for penile rehabilitation after nerve-sparing radical prostatectomy
Amr Abdel Raheem et al.
BJU INTERNATIONAL (2014)
Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression
L. Wyler et al.
BRITISH JOURNAL OF CANCER (2014)
Mechanisms of lymphatic metastasis
Sinem Karaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer
Peter D. Caie et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
Stefanie Regine Dannenmann et al.
ONCOIMMUNOLOGY (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Damya Laoui et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Tumor Lymphangiogenesis and Metastasis to Lymph Nodes Induced by Cancer Cell Expression of Podoplanin
Leah N. Cueni et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity
Marcella M. Baldewijns et al.
BJU INTERNATIONAL (2009)
Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
Hanne Krogh Jensen et al.
CLINICAL CANCER RESEARCH (2009)
Defective Infiltration of Natural Killer Cells in MICA/B-Positive Renal Cell Carcinoma Involves β2-Integrin-Mediated Interaction
Guiseppe Sconocchia et al.
NEOPLASIA (2009)
Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma
Akio Horiguchi et al.
UROLOGY (2008)
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier et al.
LANCET (2007)
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer
Kirsten D. Mertz et al.
HUMAN PATHOLOGY (2007)
Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum
Pedram Argani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The adaptive immunologic microenvironment in colorectal cancer: A novel perspective
Jerome Galon et al.
CANCER RESEARCH (2007)
Pathways targeting tumor lymphangiogenesis
Christoph Wissmann et al.
CLINICAL CANCER RESEARCH (2006)
Tumor and lymph node lymphangiogenesis - impact on cancer metastasis
Nadja E. Tobler et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases
SM Bonsib
MODERN PATHOLOGY (2006)
The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors
U Fiedler et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Expression and quantification of LYVE-1 in human colorectal cancer
F. Gao et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2006)
A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity
T Kato et al.
BRITISH JOURNAL OF CANCER (2005)
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
SS Dadras et al.
MODERN PATHOLOGY (2005)
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
V Schacht et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The renal sinus is the principal invasive pathway - A prospective study of 100 renal cell carcinomas
SM Bonsib
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer
P Bono et al.
CLINICAL CANCER RESEARCH (2004)
Lymphangiogenesis and cancer metastasis
SA Stacker et al.
NATURE REVIEWS CANCER (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)